Kempharm, Inc (KMPH)

Trade KMPH now with
1/23/2018 7:35:33 AM KemPharm Receives Patent Grant For KP606, A Prodrug Of Oxycodone
1/8/2018 7:38:34 AM KemPharm Initiates Pivotal Efficacy Trial Of KP415
11/16/2017 7:30:58 AM KemPharm Completes End-of-Phase 2 Meeting On KP415 With FDA
10/4/2017 7:34:28 AM KemPharm, Genco To Develop Prodrug-Based Therapy For Rare Pediatric Indications Of Tourette’s Syndrome With ADHD
9/20/2017 7:33:53 AM KemPharm Files IND For KP484 For Treatment Of ADHD, An Investigational Prodrug Of Methylphenidate
9/12/2017 7:16:02 AM KemPharm Announces FDRR Process Completion And Resubmission Of The Apadaz NDA
8/10/2017 7:33:08 AM KemPharm Announces Preliminary Results From KP415 Pharmacokinetic Single And Multiple Dose Trial
8/8/2017 7:47:05 AM KemPharm Publishes Study Of Intranasal Abuse Of Hydrocodone Combination Products In Pharmacoepidemiology & Drug Safety